Report : Asia Pacific Airway Management Devices Market Forecast to 2028 – COVID-19 Impact and Regional Analysis – by Product [Infraglottic Devices (Endotracheal Tubes, Tracheostomy Tubes, and Others), Supraglottic Devices, Laryngoscopes, Resuscitators, and Others] and End User (Hospitals, Ambulatory Surgical Care Centers, and Others)

At 7.3% CAGR, the Asia Pacific Airway Management Devices Market is speculated to be worth US$ 597.49 million by 2028, says Business Market Insights

According to Business Market Insights’ research, the Asia Pacific airway management devices market was valued at US$ 391.18 million in 2022 and is expected to reach US$ 597.49 million by 2028, registering a CAGR of 7.3% from 2022 to 2028. Extending demand for single-use airway management devices and rising research and development activities and collaborations among market players are factors boosting the growth of the market.

There has been significant development in healthcare facilities and services, which has increased the demand for various products, including single-use devices. Nowadays, single-use devices are widely used on a global level owing to several benefits, such as increased patient safety, reduced healthcare-associated infections, and better management of respiratory infectious diseases. Single-use airway management devices are pre-sterilized and can be directly used, saving a lot of cleaning and sterilization time. These devices are widely used for handling patients suffering from highly infectious diseases, such as severe pneumonia and H1N1 influenza. Moreover, the COVID-19 pandemic has created the demand for single-use airway management devices to treat COVID-19 patients, which is further expected to reduce the spread of infections. Additionally, severe cases of COVID-19 require ventilator support and intubation, which has increased the use of single-use tracheal tubes. Furthermore, the rising number of emergency cases, such as heart attack, stroke, breathing difficulties, and fatal road accidents, along with the increasing burden of the aging population prone to respiratory disorders, is expected to create growth opportunities. Additionally, the surge in the R&D investments and funds granted by government bodies to improve the emergency care infrastructure and services is further expected to create opportunities for market growth in the coming years.  
On the contrary, higher product recalls and lack of reimbursement policies are factors restraining the growth of the market.

Based on product, the Asia Pacific airway management devices market is segmented into infraglottic devices, supraglottic devices, laryngoscopes, resuscitators, and others. The Infraglottic devices segment held 37.7% market share in 2022, amassing US$ 147.39 million. It is projected to garner US$ 224.39 million by 2028 to expand at 7.3% CAGR during 2022–2028.

Based on end user, the Asia Pacific airway management devices market is categorized into hospitals, ambulatory surgical care centers, and others. The hospitals segment held 75.5% market share in 2022, amassing US$ 295.33 million. It is projected to garner US$ 450.24 million by 2028 to expand at 7.3% CAGR during 2022–2028.

Based on country, the Asia Pacific airway management devices market has been segmented into Australia, China, India, Japan, South Korea, and Rest of APAC. Our regional analysis states that China captured 28.6% market share in 2022. It was assessed at US$ 111.81 million in 2022 and is likely to hit US$ 170.94 million by 2028, exhibiting a CAGR of 7.3% during the forecast period.

Key players dominating the Asia Pacific airway management devices market are Teleflex Incorporated; Smiths Medical; Medtronic; Intersurgical Ltd; Ambu A/S; Medline Industries, Inc.; Koninklijke Philips N.V.; ARMSTRONG MEDICAL; and Cook Medical LLC among others.

Contact Us
Contact Person: Sameer Joshi
Phone: +1- 646- 491- 9876
Email id: sam@businessmarketinsights.com

Download Free PDF Brochure